November 19, 2015

Salk scientists make serotonin-transmitting neurons in a dish

The ability to turn human skin cells into neurons that produce serotonin will be a boon for researchers

Salk News


Salk scientists make serotonin-transmitting neurons in a dish

The ability to turn human skin cells into neurons that produce serotonin will be a boon for researchers

LA JOLLA—Scientists at the Salk Institute have taken human skin cells and turned them into neurons that signal to one another using serotonin, a brain chemical that is crucial to our mental well-being.

Although serotonin neurons comprise only a small fraction of the brain’s cells, these neurons are tied to debilitating disorders such as major depression, schizophrenia and autism. Depression is commonly treated using selective serotonin reuptake inhibitors, which heighten serotonin signaling in the small gaps between neighboring neurons.

Described October 27, 2015 in Molecular Psychiatry, the method gives researchers a new lens with which to study serotonin’s mechanisms and how they may go awry in mental illness.

Scientists have created serotonin-signaling neurons from human skin cells
Scientists have created serotonin-signaling neurons from human skin cells

Click here for a high-resolution image.

Image: Krishna Vadodaria/Salk Institute

“We can finally start asking questions about cells from people affected by depression and other disorders,” says Salk Professor Rusty Gage, the study’s senior investigator.

Scientists have long been producing specialized types of human cells for study in culture dishes. For nearly a decade, for example, it has been possible to transform the cells of specific tissues, converting them into pluripotent stem cells (iPS) and, in turn, prompting them to develop into other types of cells, including neurons. Although more recent methods have turned skin cells directly into neurons, those neurons use a different brain chemical, glutamate.

In the new study, the Salk team isolated the minority population of serotonin neurons that were differentiated from stem cells and asked what unique genes were activated in these cells. The researchers then found a cocktail of six gene-activating proteins that worked to direct differentiation to serotonergic neurons directly from human fibroblasts.

“When I looked into the microscope and saw serotonin positive neurons, it was really exciting and the moment when I said, ‘Wow, we’ve got serotonergic neurons!’” says the study’s lead author Krishna Vadodaria, a research associate in the Gage laboratory. “While these neurons may not be identical to the brain’s serotonergic neurons, the iSNs have functional properties of neurons, produce serotonin and respond to antidepressants in the dish, which will help us more accurately study serotonergic neurotransmission in neuropsychiatric disorders.”

Other authors on the study include Jerome Mertens, Apua Paquola, Cedric Bardy, Xinyi Li, Roberto Jappelli, Lianna Fung, Carol Marchetto, Michael Hamm and Mark Gorris, all of the Salk Institute; and Philipp Koch of the University of Bonn in Germany.

This study was supported by the Swiss National Science Foundation (SNSF), the
Glenn Center for Aging Research, the FP7 Marie Curie, Lynn and Edward Streim, the Robert and Mary Jane Engman Foundation, the JPB Foundation, and the Leona M. and Harry B. Helmsley Charitable Trust.

PUBLICATION INFORMATION

JOURNAL

Molecular Psychiatry

TITLE

Generation of functional human serotonergic neurons from fibroblasts

AUTHORS

KC Vadodaria, J Mertens, A Paquola, C Bardy, X Li, R Jappelli, L Fung1, MC Marchetto, M Hamm, M Gorris, P Koch and FH Gage

Research Areas

For More Information

Office of Communications
Tel: (858) 453-4100
press@salk.edu

The Salk Institute For Biological Studies:

Unlocking the secrets of life itself is the driving force behind the Salk Institute. Our team of world-class, award-winning scientists pushes the boundaries of knowledge in areas such as neuroscience, cancer research, aging, immunobiology, plant biology, computational biology and more. Founded by Jonas Salk, developer of the first safe and effective polio vaccine, the Institute is an independent, nonprofit research organization and architectural landmark: small by choice, intimate by nature, and fearless in the face of any challenge.